Published in Matrix Biol on March 02, 2016
Matrix elasticity directs stem cell lineage specification. Cell (2006) 43.00
A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J (2011) 10.70
Bone morphogenetic proteins. Growth Factors (2004) 8.61
Polymeric system for dual growth factor delivery. Nat Biotechnol (2001) 7.20
Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture. Science (2010) 6.67
Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci U S A (1986) 5.34
Electrospinning of collagen nanofibers. Biomacromolecules (2002) 4.51
Bone morphogenetic protein receptors and signal transduction. J Biochem (2009) 4.51
Bone substitutes: an update. Injury (2005) 4.49
Calcium phosphate ceramics as hard tissue prosthetics. Clin Orthop Relat Res (1981) 3.81
Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci U S A (1975) 3.46
Autogenous iliac crest bone graft. Complications and functional assessment. Clin Orthop Relat Res (1997) 3.29
Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J Periodontol (2005) 3.24
Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J (2007) 2.85
Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J (2003) 2.85
Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface (2010) 2.69
Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res (2008) 2.64
Bone recognition mechanism of porcine osteocalcin from crystal structure. Nature (2003) 2.35
Vascularization strategies for tissue engineering. Tissue Eng Part B Rev (2009) 2.31
A method for decarboxylation of gamma-carboxyglutamic acid in proteins. Properties of the decarboxylated gamma-carboxyglutamic acid protein from calf bone. J Biol Chem (1979) 2.30
Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J Biol Chem (1998) 2.26
Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone (2008) 2.19
Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials (2009) 1.87
Therapeutic angiogenesis in cardiovascular disease. Nat Rev Drug Discov (2003) 1.84
Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med (2008) 1.77
Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO J (2004) 1.77
Method development of efficient protein extraction in bone tissue for proteome analysis. J Proteome Res (2007) 1.71
Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng Part A (2009) 1.67
Recombinant human platelet-derived growth factor: biology and clinical applications. J Bone Joint Surg Am (2008) 1.66
Biomimetic nanofibrous scaffolds for bone tissue engineering. Biomaterials (2011) 1.63
Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol (2003) 1.63
Type I collagen-induced osteoblastic differentiation of bone-marrow cells mediated by collagen-alpha2beta1 integrin interaction. J Cell Physiol (2000) 1.59
Strategies for controlled delivery of growth factors and cells for bone regeneration. Adv Drug Deliv Rev (2012) 1.57
Vascular endothelial growth factor family of ligands and receptors: review. Blood Cells Mol Dis (2007) 1.56
Matrices and scaffolds for protein delivery in tissue engineering. Adv Drug Deliv Rev (2007) 1.55
Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med (2008) 1.54
Recent advances in 3D printing of biomaterials. J Biol Eng (2015) 1.54
Vertical ridge augmentation by means of deproteinized bovine bone block and recombinant human platelet-derived growth factor-BB: a histologic study in a dog model. Int J Periodontics Restorative Dent (2006) 1.53
3D printing of composite calcium phosphate and collagen scaffolds for bone regeneration. Biomaterials (2014) 1.52
Collagen-hydroxyapatite composites for hard tissue repair. Eur Cell Mater (2006) 1.49
Osteoblast-related gene expression of bone marrow cells during the osteoblastic differentiation induced by type I collagen. J Biochem (2001) 1.46
Influence of recombinant human platelet-derived growth factor on lateral ridge augmentation using biphasic calcium phosphate and guided bone regeneration: a histomorphometric study in dogs. J Periodontol (2009) 1.44
Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair. Bone (2004) 1.43
The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone. J Bone Joint Surg Am (2001) 1.42
Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev (2005) 1.42
Electro-spinning of pure collagen nano-fibres - just an expensive way to make gelatin? Biomaterials (2008) 1.40
Growth factor binding to the pericellular matrix and its importance in tissue engineering. Adv Drug Deliv Rev (2007) 1.39
Targeting angiogenesis: structural characterization and biological properties of a de novo engineered VEGF mimicking peptide. Proc Natl Acad Sci U S A (2005) 1.38
Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone. J Periodontol (2003) 1.37
Tethered epidermal growth factor as a paradigm for growth factor-induced stimulation from the solid phase. Nat Med (1996) 1.36
Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater (2008) 1.34
The clinical use of allografts, demineralized bone matrices, synthetic bone graft substitutes and osteoinductive growth factors: a survey study. HSS J (2005) 1.34
Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone (1994) 1.31
Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues. Biomaterials (2009) 1.31
Osteoinduction by calcium phosphate biomaterials. J Mater Sci Mater Med (1998) 1.31
The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. Biomaterials (2009) 1.30
Osteonectin cDNA sequence reveals potential binding regions for calcium and hydroxyapatite and shows homologies with both a basement membrane protein (SPARC) and a serine proteinase inhibitor (ovomucoid). Proc Natl Acad Sci U S A (1988) 1.30
Collagen-binding growth factors: production and characterization of functional fusion proteins having a collagen-binding domain. Proc Natl Acad Sci U S A (1998) 1.30
Binding of bone sialoprotein, osteopontin and synthetic polypeptides to hydroxyapatite. Connect Tissue Res (2001) 1.30
Coordinate regulation of cell growth and differentiation by TGF-beta superfamily and Runx proteins. Oncogene (2004) 1.29
'Magic bullets' for bone diseases: progress in rational design of bone-seeking medicinal agents. Chem Soc Rev (2006) 1.29
Bone Morphogenetic Protein (BMP) signaling in development and human diseases. Genes Dis (2014) 1.27
Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. J Biomed Mater Res (2002) 1.23
Acidic amino acid-rich sequences as binding sites of osteonectin to hydroxyapatite crystals. Biochim Biophys Acta (1996) 1.22
Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2). J Spinal Disord Tech (2006) 1.22
Modular peptides promote human mesenchymal stem cell differentiation on biomaterial surfaces. Acta Biomater (2009) 1.19
The promotion of microvasculature formation in poly(ethylene glycol) diacrylate hydrogels by an immobilized VEGF-mimetic peptide. Biomaterials (2011) 1.17
Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: Current challenges in BMP delivery. Biotechnol Lett (2009) 1.17
Platelet-derived growth factor applications in periodontal and peri-implant bone regeneration. Expert Opin Biol Ther (2011) 1.17
Attachment of osteoblastic cells to hydroxyapatite crystals by a synthetic peptide (Glu7-Pro-Arg-Gly-Asp-Thr) containing two functional sequences of bone sialoprotein. Matrix Biol (1997) 1.14
Osteoinduction by biomaterials--physicochemical and structural influences. J Biomed Mater Res A (2006) 1.14
The influence of scaffold elasticity on germ layer specification of human embryonic stem cells. Biomaterials (2011) 1.13
Bone morphogenetic protein delivery systems. Spine (Phila Pa 1976) (2002) 1.13
Selective delivery of estradiol to bone by aspartic acid oligopeptide and its effects on ovariectomized mice. Endocrinology (2001) 1.12
Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor. Tissue Eng (2004) 1.12
Increasing the pore sizes of bone-mimetic electrospun scaffolds comprised of polycaprolactone, collagen I and hydroxyapatite to enhance cell infiltration. Biomaterials (2011) 1.11
Activation of osteo-progenitor cells by a novel synthetic peptide derived from the bone morphogenetic protein-2 knuckle epitope. Biochim Biophys Acta (2003) 1.10
Accelerated fracture healing in the geriatric, osteoporotic rat with recombinant human platelet-derived growth factor-BB and an injectable beta-tricalcium phosphate/collagen matrix. J Orthop Res (2008) 1.10
The adsorption of preferential binding peptides to apatite-based materials. Biomaterials (2008) 1.07
Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2. Biomaterials (2006) 1.07
BMP induced inflammation: a comparison of rhBMP-7 and rhBMP-2. J Orthop Res (2012) 1.07
Mesenchymal stem cell responses to bone-mimetic electrospun matrices composed of polycaprolactone, collagen I and nanoparticulate hydroxyapatite. PLoS One (2011) 1.05
Repair of 20-mm long rabbit radial bone defects using BMP-derived peptide combined with an alpha-tricalcium phosphate scaffold. J Biomed Mater Res A (2006) 1.03
Covalent growth factor immobilization strategies for tissue repair and regeneration. Macromol Biosci (2011) 1.02
Enhanced biomineralization in osteoblasts on a novel electrospun biocomposite nanofibrous substrate of hydroxyapatite/collagen/chitosan. Tissue Eng Part A (2010) 1.02
Growth factor delivery approaches in hydrogels. Biomacromolecules (2009) 1.02
Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. J Control Release (2000) 1.02
Sustained epidermal growth factor receptor levels and activation by tethered ligand binding enhances osteogenic differentiation of multi-potent marrow stromal cells. J Cell Physiol (2009) 1.02
rhBMP-2 injected in a calcium phosphate paste (alpha-BSM) accelerates healing in the rabbit ulnar osteotomy model. J Orthop Res (2003) 1.02
A modular, hydroxyapatite-binding version of vascular endothelial growth factor. Adv Mater (2010) 1.01
Enhancement of osteogenesis on hydroxyapatite surface coated with synthetic peptide (EEEEEEEPRGDT) in vitro. J Biomed Mater Res (2002) 1.01
Fibronectin at select sites binds multiple growth factors and enhances their activity: expansion of the collaborative ECM-GF paradigm. J Invest Dermatol (2013) 1.01
Electrospun nanostructured scaffolds for bone tissue engineering. Acta Biomater (2009) 1.01
Influence of hydroxyapatite-coated and growth factor-releasing interference screws on tendon-bone healing in an ovine model. Arthroscopy (2009) 1.01
Matrix-Bound VEGF Mimetic Peptides: Design and Endothelial Cell Activation in Collagen Scaffolds. Adv Funct Mater (2011) 1.01
Accelerated bone repair with the use of a synthetic BMP-2-derived peptide and bone-marrow stromal cells. J Biomed Mater Res A (2005) 1.00
VEGF incorporated into calcium phosphate ceramics promotes vascularisation and bone formation in vivo. Eur Cell Mater (2010) 1.00
Regulation of in vitro calcium phosphate mineralization by combinatorially selected hydroxyapatite-binding peptides. Biomacromolecules (2008) 1.00
Prolonged ectopic calcification induced by BMP-2-derived synthetic peptide. J Biomed Mater Res A (2004) 0.99
The effect of recombinant human bone morphogenetic protein-2 on femoral reconstruction with an intercalary allograft in a dog model. J Orthop Res (2001) 0.98